Vivos Therapeutics Inc (VVOS)

2026-08-28T12:50:10.000Z - 2 days ago

Vivos Therapeutics, SPCVA to launch regional sleep testing and treatment center

Aug 28, 2026, 8:45 AM EDT - 2 days ago

Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center

2026-08-25T12:56:23.000Z - 5 days ago

Vivos Therapeutics reports new patient referrals at Nevada Sleep & Airway

Aug 25, 2026, 8:45 AM EDT - 5 days ago

Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers

2026-08-20T14:30:19.000Z - 10 days ago

Vivos Therapeutics opens sleep testing, treatment facility in Nevada

Aug 20, 2026, 10:24 AM EDT - 10 days ago

Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment

Aug 14, 2026, 5:00 PM EDT - 16 days ago

Vivos Therapeutics Earnings Call Transcript: Q2 2026

Aug 14, 2026, 5:00 PM EDT - 16 days ago

Vivos Therapeutics Quarterly report: Q2 2026

Aug 14, 2026, 4:28 PM EDT - 16 days ago

Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update

Aug 14, 2026, 8:45 AM EDT - 16 days ago

Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call

2026-08-11T13:11:51.000Z - 19 days ago

Vivos Therapeutics expands strategic engagement with Greenway Health

Aug 11, 2026, 8:45 AM EDT - 19 days ago

Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations

2026-08-05T14:01:57.000Z - 25 days ago

Vivos Therapeutics issued new U.S. patent for Vivos CARE devices

Aug 5, 2026, 8:30 AM EDT - 25 days ago

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

2026-07-08T18:10:16.000Z - 7 weeks ago

Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global

2026-06-30T13:35:46.000Z - 2 months ago

Vivos Therapeutics says Vida oral appliance improves insomnia in study

Jun 30, 2026, 8:45 AM EDT - 2 months ago

Vivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants

Jun 22, 2026, 8:30 AM EDT - 2 months ago

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

2026-06-11T12:55:08.000Z - 2 months ago

Vivos Therapeutics intends to file registration statement for rights offering

Jun 11, 2026, 8:30 AM EDT - 2 months ago

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

2026-06-10T13:18:43.000Z - 2 months ago

Vivos Therapeutics enters pact with South Palm Cardiovascular Associates

Jun 10, 2026, 9:03 AM EDT - 2 months ago

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

Jun 9, 2026, 11:30 AM EDT - 2 months ago

Vivos Therapeutics Transcript: WTR Insights Conference: Powered by The Small Cap Showcase

Jun 8, 2026, 1:39 PM EDT - 2 months ago

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

Jun 5, 2026, 8:45 AM EDT - 3 months ago

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

2026-05-20T20:22:09.000Z - 3 months ago

Vivos Therapeutics reports Q1 EPS (52c), consensus (45c)

May 20, 2026, 4:10 PM EDT - 3 months ago

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

May 20, 2026, 4:00 PM EDT - 3 months ago

Vivos Therapeutics Quarterly report: Q1 2026

May 20, 2026, 4:00 PM EDT - 3 months ago

Vivos Therapeutics Earnings release: Q1 2026

May 9, 2026, 11:53 AM EDT - 4 months ago

Analysts see 200%+ upside in these 3 high-risk stocks: here's why?

ACTU ATAI

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Vivos Therapeutics Registration statement: Registration filing

2026-04-17T13:52:17.000Z - 4 months ago

Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright

2026-04-17T12:43:47.000Z - 4 months ago

Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global

Apr 15, 2026, 5:00 PM EDT - 4 months ago

Vivos Therapeutics Earnings Call Transcript: Q4 2025

Apr 15, 2026, 5:00 PM EDT - 4 months ago

Vivos Therapeutics Earnings release: Q4 2025

Apr 15, 2026, 5:00 PM EDT - 4 months ago

Vivos Therapeutics Annual report: Q4 2025

Apr 15, 2026, 4:20 PM EDT - 4 months ago

Vivos Therapeutics Reports Full Year 2025 Financial Results

Apr 15, 2026, 8:45 AM EDT - 4 months ago

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

Apr 7, 2026, 8:45 AM EDT - 5 months ago

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

Mar 26, 2026, 8:45 AM EDT - 5 months ago

Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

2026-03-17T13:00:18.000Z - 5 months ago

Vivos Therapeutics’ oral medical devices proven to enhance airways

Mar 17, 2026, 8:45 AM EDT - 5 months ago

Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

Feb 17, 2026, 7:00 AM EST - 6 months ago

Vivos Therapeutics Registration statement: Registration Filing

2026-02-17T11:15:45.000Z - 6 months ago

Vivos Therapeutics files to sell 3.96M shares of common stock for holders

2026-02-05T13:50:40.000Z - 7 months ago

Vivos, SoundHealth collaborate to expand access to SoundHealth’s technology

2026-02-05T13:50:12.000Z - 7 months ago

Vivos Therapeutics signs 12-part media series with New to the Street

Feb 5, 2026, 8:45 AM EST - 7 months ago

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Jan 20, 2026, 5:31 PM EST - 7 months ago

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

2026-01-16T13:10:49.000Z - 8 months ago

Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds

Jan 16, 2026, 8:00 AM EST - 8 months ago

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Dec 16, 2025, 11:00 AM EST - 9 months ago

Vivos Therapeutics Transcript: Fireside Chat

2025-12-16T13:50:29.000Z - 9 months ago

Vivos Therapeutics opens sleep center in Auburn Hills, Michigan

Dec 16, 2025, 8:45 AM EST - 9 months ago

Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

Nov 19, 2025, 5:00 PM EST - 10 months ago

Vivos Therapeutics Earnings Call Transcript: Q3 2025

Nov 19, 2025, 5:00 PM EST - 10 months ago

Vivos Therapeutics Earnings release: Q3 2025

Nov 19, 2025, 5:00 PM EST - 10 months ago

Vivos Therapeutics Quarterly report: Q3 2025

2025-11-19T21:30:18.000Z - 10 months ago

Vivos Therapeutics reports Q3 EPS (49c), consensus (51c)

Nov 19, 2025, 4:20 PM EST - 10 months ago

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Nov 19, 2025, 8:30 AM EST - 10 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

2025-11-17T11:15:44.000Z - 10 months ago

Vivos Therapeutics initiated with a Buy at H.C. Wainwright

Sep 30, 2025, 8:30 AM EDT - 11 months ago

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Sep 29, 2025, 8:00 AM EDT - 11 months ago

Vivos Therapeutics Proxy statement: Proxy Filing

Sep 17, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

Sep 5, 2025, 8:00 AM EDT - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Aug 19, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q2 2025

Aug 19, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings release: Q2 2025

Aug 19, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Quarterly report: Q2 2025

Aug 19, 2025, 4:20 PM EDT - 1 year ago

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Aug 19, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

Jun 26, 2025, 8:30 AM EDT - 1 year ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q1 2025

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings release: Q1 2025

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Quarterly report: Q1 2025

May 14, 2025, 9:15 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q4 2024

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings release: Q4 2024

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Annual report: Q4 2024

Mar 31, 2025, 4:20 PM EDT - 1 year ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Feb 18, 2025, 12:00 PM EST - 1 year ago

Vivos Therapeutics Transcript: Fireside Chat

Feb 11, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Jan 29, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Jan 22, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Dec 23, 2024, 8:00 AM EST - 1 year ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Quarterly report: Q3 2024

Nov 13, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Nov 6, 2024, 7:00 AM EST - 1 year ago

Vivos Therapeutics Proxy statement: Proxy Filing

Oct 8, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Oct 7, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Proxy statement: Proxy Filing

Sep 18, 2024, 7:00 AM EDT - 2 years ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q2 2024

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Quarterly report: Q2 2024

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q2 2024

Aug 14, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 14, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Jun 27, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 12, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Quarterly report: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q1 2024

May 14, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 14, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Apr 22, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Apr 9, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q4 2023

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q4 2023

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Annual report: Q4 2023

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 28, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Feb 6, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Jan 8, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA